Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Preventing Adverse Outcomes of Neonatal Hypoxic Ischaemic Encephalopathy With Erythropoietin: A Phase III Randomised Placebo Controlled Multicentre Clinical Trial
Brief Summary: Double-blind, placebo controlled Phase III trial of erythropoietin for hypoxic ischaemic encephalopathy in infants receiving hypothermia. The study aim is to determine whether Epo in conjunction with hypothermia in infants with moderate/severe HIE will improve neurodevelopmental outcomes at 2 years of age, without significant adverse effects, when compared to hypothermia alone.